UnitedHealth second-quarter medical costs miss estimates, shares slide
By Caroline Humer and Tamara Mathias (Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday reported second-quarter medical costs slightly higher than Wall Street expectations, sending its shares down 4 percent and weighing on the rest of the sector
By Caroline Humer and Tamara Mathias
(Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday reported second-quarter medical costs slightly higher than Wall Street expectations, sending its shares down 4 percent and weighing on the rest of the sector.
UnitedHealth is the first health insurer to report earnings, and Wall Street investors took their cue from the slight costs miss to sell shares in Anthem Inc, Cigna Corp and Humana Inc.
The Trump administration has begun to issue new rules and regulations to roll back some of the insurance coverage expansion that took place with Obamacare, former President Barack Obama's 2010 health law, and implementing new laws. UnitedHealth said it expects the debate to continue into 2019.
The government also wants to bring down high drug prices, including examining if the role of pharmacy benefit managers like UnitedHealth's Optum contributes to those price increases. The company said it is trying to lower prices on drugs for customers.
UnitedHealth's medical loss ratio, or the percentage of premiums paid out for medical services, was 81.9 percent in the quarter, short of the consensus estimate of 81.8 percent, according to healthcare investment bank Leerink.
While the ratio was actually better than the 82.2 percent a year ago, the company typically beats Wall Street estimates.
Investors are focusing on the cost trend and that's why other insurer shares were down and hospital stocks were up Tuesday, Michael Newshel, an analyst at Evercore ISI, said.
"Management said (the) costs trend is still tracking in line with what they priced for and guided to, but expectations were elevated for outperformance on the medical loss ratio metric," he added.
The stock, up nearly 17 percent this year, fell 3.5 percent to $248. Anthem was down 1.7 percent to $242.41, Cigna was off 1.9 percent to $169.70 and Humana decreased 2.4 percent to $308.25.
UnitedHealth Chief Financial Officer John Rex said on a conference call with analysts that the medical cost ratio was within expectations and sees a range of 81.5 percent, plus or minus 0.50 percentage points, in 2018.
The slight miss overshadowed the company's earnings beat and its higher full-year earnings forecast.
Medicare Advantage plans, which provide government-paid health insurance to people over 65 or those who are disabled, brought in $2.1 billion more in sales from a year earlier.
The company now expects adjusted earnings of $12.50 to $12.75 per share in the year, compared with its previous forecast of $12.40 to $12.65.
Net earnings rose 28 percent to $2.92 billion in the quarter.
Excluding items, the company earned $3.14 per share, above the average analyst estimate of $3.04, according to Thomson Reuters I/B/E/S.
(Reporting by Tamara Mathias in Bengaluru and Caroline Humer in New York; Editing by Maju Samuel and Jeffrey Benkoe)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Jessica Resnick-Ault NEW YORK (Reuters) - Oil prices strengthened on Wednesday, as OPEC and its allies were seen complying with a pact to cut oil supply in September, even as concerns loomed that recovery in fuel demand will be stalled by soaring global coronavirus cases. Early in the day crude was boosted by a bullish stock market. Even as equities whipsawed on pandemic worries, oil stayed higher, buoyed by expectations that OPEC could staunch a supply glut
By Tina Bellon and C Nivedita (Reuters) - Tesla Inc will further cut the price of its Model S "Long Range" sedan in the United States to $69,420, the electric carmaker's chief executive, Elon Musk, announced in a tweet https://bit.ly/2H0JCP0 on Wednesday. The anticipated drop marks the second time this week Tesla has cut the price for the high-end sedan, following a 4% cut of the Model S's price in the United States on Tuesday to $71,990.
By Jeff Mason DES MOINES, Iowa (Reuters) - Under siege over his handling of the novel coronavirus pandemic, President Donald Trump on Wednesday cited what he said was his son's mild bout of the virus as a reason why American schools should reopen as soon as possible. Trump made the comment about his son, Barron, as the president swept into Iowa on a mission to shore up support in battleground states that he won in 2016 but is in danger of losing to Democrat Joe Biden barely three weeks before the election. First lady Melania Trump announced in a statement earlier in the day that the virus that struck both her and her husband had also infected their 14-year-old son